![Luigi Colombo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luigi Colombo is the founder of Biosearch Italia SpA, which was founded in 1996.
He is currently the Chief Executive Officer at SilverAid SRL, the Director at Nocturnal Labs SpA, and the Chief Operating Officer at EPOK Therapeutics, Inc. (starting in 2023).
Mr. Colombo previously worked as the Executive Director at Ulisse BioMed SpA. He obtained his undergraduate degree from the University of Milan.
| Sociétés | Poste | Début |
|---|---|---|
EPOK Therapeutics, Inc.
 EPOK Therapeutics, Inc. BiotechnologyHealth Technology Develops biologics to treat metabolic diseases | Directeur des opérations | 01/02/2023 |
SilverAid SRL
 SilverAid SRL Medical SpecialtiesHealth Technology Designs, develops, produces and distributes dental equipment | Directeur Général | - |
Nocturnal Labs SpA | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Biosearch Italia SpA
 Biosearch Italia SpA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Fondateur | - |
| HELYX INDUSTRIES S.P.A. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Biosearch Italia SpA
Biosearch Italia SpA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Milan
 University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ulisse BioMed SpA
 Ulisse BioMed SpA Medical SpecialtiesHealth Technology Develops and manufactures diagnostic platforms and products | Health Technology |
SilverAid SRL
SilverAid SRL Medical SpecialtiesHealth Technology Designs, develops, produces and distributes dental equipment | Health Technology |
EPOK Therapeutics, Inc.
EPOK Therapeutics, Inc. BiotechnologyHealth Technology Develops biologics to treat metabolic diseases | Health Technology |
Nocturnal Labs SpA |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
